These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37852207)

  • 1. Risk Factors for Neurodevelopmental Impairment at 2- and 5-Years Corrected Age in Preterm Infants with Established Bronchopulmonary Dysplasia.
    Katz TA; van Kaam AH; Mugie SM; Aarnoudse-Moens CSH; de Groof F; van Kempen AAMW; van den Heuvel MEN; Vogelzang J; Rijpert M; Schiering IA; Koomen-Botman I; Visser F; Leemhuis AG; Onland W
    Neonatology; 2024; 121(1):125-132. PubMed ID: 37852207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
    Thomas SR; Jain SK; Murthy P; Joseph CJ; Soraisham A; Tang S; Dosani A; Lodha A
    Am J Perinatol; 2024 May; 41(S 01):e2505-e2513. PubMed ID: 37399847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
    Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
    Yang T; Shen Q; Wang S; Dong T; Liang L; Xu F; He Y; Li C; Luo F; Liang J; Tang C; Yang J
    BMC Pediatr; 2022 Apr; 22(1):200. PubMed ID: 35413820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of Bronchopulmonary Dysplasia and Neurodevelopmental Outcome at 2 and 5 Years Corrected Age.
    Katz TA; Vliegenthart RJS; Aarnoudse-Moens CSH; Leemhuis AG; Beuger S; Blok GJ; van Brakel MJM; van den Heuvel MEN; van Kempen AAMW; Lutterman C; Rijpert M; Schiering IA; Ran NC; Visser F; Wilms J; van Kaam AH; Onland W
    J Pediatr; 2022 Apr; 243():40-46.e2. PubMed ID: 34929243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of severity and age with variable definitions of bronchopulmonary dysplasia on neurodevelopmental outcomes.
    Donlon J; Bhat V; Hunter K; Kushnir A; Bhandari V
    Pediatr Res; 2024 Oct; 96(5):1243-1250. PubMed ID: 38830970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcomes of extremely preterm infants with bronchopulmonary dysplasia (BPD) - A retrospective cohort study.
    Nguyen KL; Fitzgerald DA; Webb A; Bajuk B; Popat H
    Paediatr Respir Rev; 2024 Jun; 50():23-30. PubMed ID: 38490918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental impairment at 2 years of age in children born before 29 weeks' gestation with bronchopulmonary dysplasia.
    Decollogne L; Epiard C; Chevallier M; Ego A; Alin L; Debillon T
    Arch Pediatr; 2021 Jan; 28(1):23-28. PubMed ID: 33257210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia.
    Gallini F; Coppola M; De Rose DU; Maggio L; Arena R; Romano V; Cota F; Ricci D; Romeo DM; Mercuri EM; Vento G
    Early Hum Dev; 2021 Jan; 152():105275. PubMed ID: 33227635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with neurodevelopmental impairment in preterm infants with bronchopulmonary dysplasia.
    Yazici A; Buyuktiryaki M; Simsek GK; Kanmaz Kutman HG; Canpolat FE
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1579-1585. PubMed ID: 35302203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of multiple placental pathologies on neonatal death, bronchopulmonary dysplasia, and neurodevelopmental impairment in preterm infants.
    Mir IN; Chalak LF; Brown LS; Johnson-Welch S; Heyne R; Rosenfeld CR; Kapadia VS
    Pediatr Res; 2020 Apr; 87(5):885-891. PubMed ID: 31812153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal outcome of small for gestational age preterm infants.
    Nobile S; Marchionni P; Carnielli VP
    Eur J Pediatr; 2017 Aug; 176(8):1083-1088. PubMed ID: 28660312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and bronchopulmonary dysplasia in preterm infants.
    Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H
    J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted Ventilation Associated with Reduced Neurodevelopmental Impairment in Preterm Infants.
    Vliegenthart RJS; Onland W; van Wassenaer-Leemhuis AG; De Jaegere APM; Aarnoudse-Moens CSH; van Kaam AH
    Neonatology; 2017; 112(2):172-179. PubMed ID: 28601870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of mechanical ventilation and neurodevelopment in preterm infants.
    Vliegenthart RJS; van Kaam AH; Aarnoudse-Moens CSH; van Wassenaer AG; Onland W
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F631-F635. PubMed ID: 30894396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression.
    Villamor-Martinez E; Álvarez-Fuente M; Ghazi AMT; Degraeuwe P; Zimmermann LJI; Kramer BW; Villamor E
    JAMA Netw Open; 2019 Nov; 2(11):e1914611. PubMed ID: 31693123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal Asthma, Preterm Birth, and Risk of Bronchopulmonary Dysplasia.
    Gage S; Kan P; Lee HC; Gould JB; Stevenson DK; Shaw GM; O'Brodovich HM
    J Pediatr; 2015 Oct; 167(4):875-880.e1. PubMed ID: 26254835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between clinical and biochemical characteristics of late-onset sepsis and bronchopulmonary dysplasia in preterm infants.
    Ebrahimi ME; Romijn M; Vliegenthart RJS; Visser DH; van Kaam AH; Onland W
    Eur J Pediatr; 2021 Jul; 180(7):2147-2154. PubMed ID: 33629121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced pulmonary oxygen diffusion at 36 weeks of postmenstrual age in small-for-gestational-age preterm infants of less than 32 weeks without bronchopulmonary dysplasia.
    Correani A; Lanciotti L; Giorgetti C; Palazzi ML; Monachesi C; Antognoli L; Burattini I; Cogo P; Carnielli V
    Pediatr Pulmonol; 2023 Nov; 58(11):3054-3062. PubMed ID: 37594147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.